LY6E as a new prognostic biomarker of multiple myeloma-related bone disease
Abstract Osteolytic bone disease, which deteriorates the quality of life, is a prevalent complication of multiple myeloma (MM). In this study, we utilized bioinformatics analysis to identify the differentially expressed genes (DEGs) associated with MM bone disease (MBD) from the Gene Expression Omni...
Saved in:
| Main Authors: | Min Shi, Jing Li, Jing Wang, Ye Yao, Xuxing Shen, Yuan Xia, Ji Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-91413-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic insights into bone destruction in multiple myeloma: Cellular and molecular perspectives
by: Oxana Lungu, et al.
Published: (2025-04-01) -
Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma
by: Ping Huang, et al.
Published: (2025-06-01) -
Enhancing prognosis in multiple myeloma bone disease: insights from a retrospective analysis of surgical interventions
by: Xiangjun Shi, et al.
Published: (2024-12-01) -
Treatment of bone complications in multiple myeloma patients
by: V. V. Ptushkin
Published: (2022-11-01) -
Impact of treatment delay of multiple myeloma bone disease on later myeloma-related skeletal events and outcome
by: Eskelinen Veera, et al.
Published: (2025-08-01)